BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 57828)

  • 1. Uridine 5'-diphosphate-galactose:glycoprotein galactosyltransferase activity in the ovarian cancer patient.
    Bhattacharya M; Chatterjee SK; Barlow JJ
    Cancer Res; 1976 Jun; 36(6):2096-101. PubMed ID: 57828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosyltransferase and glycosidase activities in ovarian cancer patients.
    Chatterjee SK; Bhattacharya M; Barlow JJ
    Cancer Res; 1979 Jun; 39(6 Pt 1):1943-51. PubMed ID: 445394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of serum glycoprotein galactosyltransferase levels in different histological types of ovarian carcinoma.
    Gauduchon P; Tillier C; Guyonnet C; Heron JF; Bar-Guilloux E; Le Talaer JY
    Cancer Res; 1983 Sep; 43(9):4491-6. PubMed ID: 6409405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of products synthesized by galactosyltransferase purified from the ascites of ovarian cancer patients.
    Chatterjee SK; Bhattacharya M; Barlow JJ
    J Natl Cancer Inst; 1986 Oct; 77(4):855-62. PubMed ID: 2429004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor markers for ovarian cancer.
    Bhattacharya M; Barlow JJ
    Int Adv Surg Oncol; 1979; 2():155-76. PubMed ID: 95453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uridine 5'-diphosphate galactose: glycoprotein galactosyl transferase activity in exfoliated bladder epithelial cells in rats fed N-(4-(5-nitro-2-furyl)-2-thiazolyl) formamide.
    Plotkin GM; Brigham SC; Wolf G; Jacobs JB; Arai M
    Cancer Biochem Biophys; 1977; 2(2):59-63. PubMed ID: 99227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine monoclonal antibodies against galactosyltransferase from the ascites of ovarian cancer patients.
    Chatterjee SK; Bhattacharya M; Barlow JJ
    Cancer Res; 1984 Dec; 44(12 Pt 1):5725-32. PubMed ID: 6209001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Localization and modulation of galactosyltransferase during in vitro proliferation of a human ovarian adenocarcinoma cell line].
    Sichel F; Bar E; Gauduchon P; Malas JP; Benard J; Le Talaer JY
    C R Acad Sci III; 1991; 312(1):19-24. PubMed ID: 1900729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies on the uridine-5'-diphosphate-galactose: glycoprotein galactosyltransferase activity in rat liver and Zajdela ascitic hepatoma.
    Ivanov D; Karaivanova V; Ivanov S; Chelibonova-Lorer H
    Cancer Biochem Biophys; 1994 Apr; 14(1):35-40. PubMed ID: 7540947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and immunoassay of human tumor-associated galactosyltransferase isoenzyme II.
    Uemura M; Winant RC; Sikic BI; Brandt AE
    Cancer Res; 1988 Sep; 48(18):5325-34. PubMed ID: 3136919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of two distinct galactosyltransferase activities in populations of mouse peritoneal macrophages.
    Sheares BT; Mercurio AM
    J Immunol; 1987 Dec; 139(11):3748-52. PubMed ID: 3119716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactosyltransferase associated with tumor in patients with ovarian cancer: factors involved in elevation of serum galactosyltransferase.
    Saitoh E; Aoki D; Susumu N; Udagawa Y; Nozawa S
    Int J Oncol; 2003 Aug; 23(2):303-10. PubMed ID: 12851678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative differences in GlcNAc:beta1-->3 and GlcNAc:beta1-->4 galactosyltransferase activities between human colonic adenocarcinomas and normal colonic mucosa.
    Seko A; Ohkura T; Kitamura H; Yonezawa S; Sato E; Yamashita K
    Cancer Res; 1996 Aug; 56(15):3468-73. PubMed ID: 8758913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of 4 beta-galactosyltransferase activity for paragloboside synthesis in sera of patients with cancer.
    Nishiwaki S; Taki T; Handa N; Hattori N; Takeshita K; Endo M; Handa S
    Cancer Res; 1992 Apr; 52(7):1875-80. PubMed ID: 1551117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the purification and properties of UDP-galactose glycoprotein galactosyltransferase from rat liver and serum.
    Fraser IH; Mookerjea S
    Biochem J; 1976 May; 156(2):347-55. PubMed ID: 821479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoassay of serum galactosyltransferase isoenzyme II in cancer patients and control subjects.
    Uemura M; Winant RC; Brandt AE
    Cancer Res; 1988 Sep; 48(18):5335-41. PubMed ID: 3136920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and immunologic characterization of galactosyltransferase purified from the ascites of ovarian cancer patients.
    Chatterjee SK; Bhattacharya M; Barlow JJ
    J Natl Cancer Inst; 1985 Aug; 75(2):237-48. PubMed ID: 3927048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated thymic and serum galactosyltransferase with low-molecular-weight acceptor activity in murine leukemia.
    Krishnaraj R; Saat YA
    Cancer Res; 1985 Aug; 45(8):3615-9. PubMed ID: 3926305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated galactosyltransferase as a new tumor marker for ovarian clear cell carcinoma.
    Nozawa S; Yajima M; Sakuma T; Udagawa Y; Kiguchi K; Sakayori M; Narisawa S; Iizuka R; Uemura M
    Cancer Res; 1990 Feb; 50(3):754-9. PubMed ID: 2105162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of glycoprotein galactosyltransferase activity in human lung cancer related to histological types.
    Kijimoto-Ochiai S; Makita A; Kameya T; Kodama T; Araki E; Yoneyama T
    Cancer Res; 1981 Jul; 41(7):2931-5. PubMed ID: 6788364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.